Basic information Safety Supplier Related
ChemicalBook >  Product Catalog >  API >  Urinary System Drugs >  Other Urinary System Drugs >  Acetohydroxamic acid

Acetohydroxamic acid

Basic information Safety Supplier Related

Acetohydroxamic acid Basic information

Product Name:
Acetohydroxamic acid
Synonyms:
  • yangwosuan
  • Acetylhydroxylamine
  • AHA
  • cetohyroxamic acid
  • Hydroxylamine, N-Acetyl-
  • Hydroxylamine,N-acetyl-
  • Lithostat
  • Methylhydroxamic acid
CAS:
546-88-3
MF:
C2H5NO2
MW:
75.07
EINECS:
208-913-8
Product Categories:
  • LITHOSTAT
  • inhibitor
  • Aromatic Carboxylic Acids, Amides, Anilides, Anhydrides & Salts
  • All Inhibitors
  • Hydroxylamines (N-Substituted)
  • Amines
  • Hydroxylamines
  • Inhibitors
  • Nitrogen Compounds
  • Organic Building Blocks
  • 546-88-3
Mol File:
546-88-3.mol
More
Less

Acetohydroxamic acid Chemical Properties

Melting point:
88-90 °C (lit.)
Boiling point:
133.7°C (rough estimate)
Density 
1.2269 (rough estimate)
refractive index 
1.4264 (estimate)
storage temp. 
Keep in dark place,Inert atmosphere,Room temperature
solubility 
Methanol (Sparingly), Water (Sparingly)
form 
Crystalline Solid
pka
8.70(at 25℃)
color 
White to pale yellow
Water Solubility 
Soluble in water.
Sensitive 
Hygroscopic
Merck 
14,63
BRN 
1739019
Stability:
Moisture and Temperature Sensitive
InChIKey
RRUDCFGSUDOHDG-UHFFFAOYSA-N
CAS DataBase Reference
546-88-3(CAS DataBase Reference)
NIST Chemistry Reference
Acetamide,N-hydroxy(546-88-3)
EPA Substance Registry System
Acetohydroxamic acid (546-88-3)
More
Less

Safety Information

Hazard Codes 
T
Risk Statements 
61-40
Safety Statements 
53-45-36/37/39-22
RIDADR 
3263
WGK Germany 
3
RTECS 
AK8157000
Hazard Note 
Toxic
PackingGroup 
II
HS Code 
29225090
Hazardous Substances Data
546-88-3(Hazardous Substances Data)
Toxicity
mmo-sat 160 mmol/plate JOPHDQ 3,557,80

MSDS

More
Less

Acetohydroxamic acid Usage And Synthesis

Description

Acetohydroxamic acid is a potent, non-competitive and irreversible inhibitor of bacterial urease (Ki≈lO-7M). This enzyme, which is widely distributed in plants and bacteria, but not in mammalian cells, catalyzes the decomposition of urea to ammonia. Elevated urinary ammonia levels can reduce the antibacterial effectiveness of a number of agents. Thus, acetohydroxamic acid is useful as adjunctive therapy to decrease urinary ammonia and alkalinity in patients with chronic urea-splitting urinary infection. Such infections are a leading cause of recurring complications and death in paraplegics.

Chemical Properties

White Crystalline Solid

Originator

Research Organics; Baylor Unk. (USA)

Uses

Acetohydroxamic acid is a potent inhibitor of bacterial urease activity and reduces urinary ammonia levels. 2-Acetohydroxamic acid loaded floating microspheres forms an efficient drug delivery system for the treatment of Helicobacter pylori.
Acetohydroxamic acid was used:
to study the mechanism of complexation of iron (III) with acetohydroxamic acid.
to study the inhibitory mechanism of lansoprazole and omeprazole on Helicobacter pyloni.
in urease inhibition studies.
for in situ generation of nitrosocarbonylmethane as a Diels-Alder dienophile.
Used in urease inhibition studies and for in situ generation of nitrosocarbonylmethane as a Diels-Alder dienophile.

Uses

A urease inhibitor. Used in the synthesis

Uses

Urease inhibitorAcetohydroxamic acid acts as a drug, as an inhibitor of bacterial and plant urease, which is used for urinary tract infections. It is also used in organic synthesis. It acts as an antiurolithic and antibacterial agent. It is involved in the study of complexation of iron(III) with acetohydroxamic acid as well as in the inhibition study of lansoprazole and omeprazole on Helicobacter pyloni. It plays an important role in the insitu generation of nitrosocarbonylmethane as a Diels-Alder dienophile. In addition to this, it is used in the treatment of kidney stones and urinary tract infections.

Definition

ChEBI: Acetohydroxamic acid is a member of the class of acetohydroxamic acids that is acetamide in which one of the amino hydrogens has been replaced by a hydroxy group. It has a role as an EC 3.5.1.5 (urease) inhibitor and an algal metabolite. It is functionally related to an acetamide. It is a tautomer of a N-hydroxyacetimidic acid.

Manufacturing Process

3 Methods of producing of acetohydroxamic acid:
1. Ethyl acetic acid ether was treated with hydroxylamine and acetohydroxamic acid was obtained.
2. Acetohydroxamic acid was obtained in the result of reaction of acetamide with hydroxylamine.
3. Acetohydroxamic acid was obtained by treatment of acetaldehyde with nitrohydroxylamine.

brand name

Lithostat (Mission).

Therapeutic Function

Urease inhibitor

General Description

Acetohydroxamic acid is a potent inhibitor of bacterial urease activity and reduces urinary ammonia levels. 2-Acetohydroxamic acid loaded floating microspheres forms an efficient drug delivery system for the treatment of Helicobacter pylori.

Side effects

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
Call your doctor at once if you have:
pounding heartbeats or fluttering in your chest;
signs of a blood clot in your leg --pain, swelling, warmth, or redness in one or both legs;
signs of a red blood cell disorder --pale or yellowed skin, dark colored urine, fever, confusion or weakness.
Common side effects may include:
headache during the first 2 days of treatment;
skin rash, warmth, tingling or redness (especially if you drink alcohol while taking acetohydroxamic acid);
upset stomach, nausea, loss of appetite;
depressed mood;
anxiety, tremors, nervousness;
hair loss.

Safety Profile

Moderately toxic by intraperitonealroute. An experimental teratogen. Other experimentalreproductive effects. Mutation data reported. When heatedto decomposition it emits toxic fumes of NOx.

Veterinary Drugs and Treatments

Acetohydroxamic acid can be used in dogs as adjunctive therapy in some cases of recurrent urolithiasis or in the treatment of persistent urinary tract infections caused by the following bacteria: E. coli, Klebsiella, Morganella morganii, Staphylococci spp., and Pseudomonas aeruginosa. Adverse effects limit its usefulness.

Acetohydroxamic acidSupplier

Hubei Ruitai Pharmaceutical Technology Co.,Ltd. Gold
Tel
15335880183
Email
ywcyt@126.com
Hubei YiKangYuan Chemical Co., Ltd. Gold
Tel
027-87182908 18064088908
Email
65824125@qq.com
Wuhan ze shan cheng Biomedical Technology Co., Ltd. Gold
Tel
027-51477051 17786425391
Email
jim@zeshancheng.com
Wuhan Xingzhongcheng Technology Co., Ltd. Gold
Tel
027-83389957 18627766980
Email
914018854@qq.com
Shandong Suihua Biotechnology Co. Ltd Gold
Tel
15689727968
Email
freesky2121@163.com